Changes

Jump to navigation Jump to search
no edit summary
Line 1: Line 1:  
Also known as '''''FeLV
 
Also known as '''''FeLV
 +
[[Image:FeLV Electron Micrograph.jpg|thumb|right|175px|FeLV Electron Micrograph [http://phil.cdc.gov/phil/home.asp Public Health Image Library] Image #5610]]
    
==Introduction==
 
==Introduction==
 +
[[Image:Kinetics of FeLV 2.jpg|thumb|right|200px|Kinetics of FeLV - Copyright Dr Brian Catchpole BVetMed PhD MRCVS]]
 +
FeLV is an oncogenic mammalian type C retrovirus which causes neoplasia ([[Lymphoma|lymphoma]]), myelosuppression ([[Regenerative and Non-Regenerative Anaemias|anaemia]]) and immunosuppression (of [[Lymphocytes#T cells|T cells]]). Three different strains are currently recognised:
 +
*FeLV-A -natural strain
 +
*FeLV-B which formed through FeLV-A recombining with endogenous retroviral sequences in the feline genome.
 +
*FeLV-C which formed from the spontaneous mutation of FeLV-A
 +
 +
The virus replicates in the oropharyngeal lymphoid tissue causing a viraemia (the virus circulates in the bloodstream) which then spreads to the systemic lymphoid tissue.
    
==Pathogenesis==
 
==Pathogenesis==
Line 9: Line 17:  
*Salivary glands
 
*Salivary glands
 
*Reproductive tract
 
*Reproductive tract
Most kittens but only 30% of adults become '''viremic''' for life without producing antibody. The condition progresses in various forms:
+
Most kittens but only 30% of adults become '''viraemic''' for life without producing antibody. The condition progresses in various forms:
*20% of viremic cats die of tumors
+
*20% of viraemic cats die of tumors
*30% of viremic cats die of FeLV-associated disease
+
*30% of viraemic cats die of FeLV-associated disease
 
*80% die within three years of exposure
 
*80% die within three years of exposure
30% of adults exposed become '''latently infected''' and can become viremic when immunosuppressed.
+
30% of adults exposed become '''latently infected''' and can become viraemic when immunosuppressed.
 
40% of exposed adults remain healthy and develop Ab and CD8+ T cells after clearing the virus, without becoming reinfected or silent carriers.
 
40% of exposed adults remain healthy and develop Ab and CD8+ T cells after clearing the virus, without becoming reinfected or silent carriers.
   Line 21: Line 29:  
*'''Thymic lymphosarcoma''': T cell tumors, with only the thymus enlarged -this may result in dyspnoea and can be confirmed by radiography
 
*'''Thymic lymphosarcoma''': T cell tumors, with only the thymus enlarged -this may result in dyspnoea and can be confirmed by radiography
 
*'''Alimentary lymphosarcoma''': B cell tumors of the Peyer's patches
 
*'''Alimentary lymphosarcoma''': B cell tumors of the Peyer's patches
 +
 +
 +
*Cutaneous horns on foot pads
 +
*Epidermal and follicular epithelial hyperplasia, epidermal giant cells, dyskeratosis, necrosis, ulceration
    
FeLV-associated disease:
 
FeLV-associated disease:
 
*'''Immunodepression''' causing secondary disease
 
*'''Immunodepression''' causing secondary disease
*'''Reproductive failure''': FeLV crosses the placenta, causing fetal resorption or viremic kittens with thymic aplasia
+
*'''Reproductive failure''': FeLV crosses the placenta, causing fetal resorption or viraemic kittens with thymic aplasia
    
==Epidemiology==
 
==Epidemiology==
Line 35: Line 47:     
There are 3 antigenic subgroups which are defined by the gp70 regulated viral response:
 
There are 3 antigenic subgroups which are defined by the gp70 regulated viral response:
*Group A is transmitted between cats and is monotypic: one vaccine covers all isolates. Infection with this viral subgroup leads to '''lymphosarcoma'''.
+
*Group A is transmitted between cats and is monotypic: one vaccine covers all isolates. Infection with this viral subgroup leads to '''[[Lymphoma|lymphosarcoma]]'''.
*Group B is recombinant with transmissible FeLV-A; infection with viruses of this subgroup increases the chance of developing '''thymic tumors'''.
+
*Group B is recombinant with transmissible FeLV-A; infection with viruses of this subgroup increases the chance of developing '''[[Thymus Neoplasia|thymic tumours]]'''.
*Group C is a mutant of subgroup A. Isolates are rare, and occur as A+C mixtures, leading to an increased chance of developing '''anemia'''.
+
*Group C is a mutant of subgroup A. Isolates are rare, and occur as A+C mixes, leading to an increased chance of developing '''[[Regenerative and Non-Regenerative Anaemias|anaemia]]'''.
    
==Diagnosis==
 
==Diagnosis==
*FeLV should be suspect in any cat with '''recurrent bacterial infections''', '''anemia''' or '''weight loss'''. Diagnostic tests available for cinfirmation of disease sttus includes:
+
*FeLV should be suspect in any cat with '''recurrent bacterial infections''', '''anemia''' or '''weight loss'''. Diagnostic tests available for confirmation of disease status include:
*'''ELISA''' for FeLV antigens (capsid protein p27 or envelope protein gp70)
+
*'''[[ELISA testing|ELISA]]''' for FeLV antigens (capsid protein p27 or envelope protein gp70)
 
*'''Immunochromatography''' is now preferred as ELISA testing can give false positives
 
*'''Immunochromatography''' is now preferred as ELISA testing can give false positives
 
*'''Virus isolation''' from heparinised blood can be performed to confirm a positive diagnosis
 
*'''Virus isolation''' from heparinised blood can be performed to confirm a positive diagnosis
*Immunofluorescence
+
*[[Immunofluorescence]]
 
*PCR
 
*PCR
 
*Rapid-Immuno-Migration
 
*Rapid-Immuno-Migration
*Western Blot
+
*[[Western blot|Western Blot]]
    
==Infection Control==
 
==Infection Control==
Line 53: Line 65:     
===Vaccination===
 
===Vaccination===
Ideally, this should take place once antigen-negative status has been determined by laboratory testing. '''Leukogen''' is a subunit vaccine (using envelope protein gp70) produced in ''E. coli'' mixed with Quill-A and alhydrogel. Others include inactivated virus and canarypox recombinants, but all MUST include FeLV-A.
+
Ideally, this should take place once antigen-negative status has been determined by laboratory testing. 'Leukogen' is a subunit vaccine (using envelope protein gp70) produced in ''E. coli'' mixed with Quill-A and alhydrogel. Others include inactivated virus and canarypox recombinants, but all MUST include FeLV-A.
 
  −
(FeLV)
  −
[[Image:FeLV Electron Micrograph.jpg|thumb|right|150px|FeLV Electron Micrograph [http://phil.cdc.gov/phil/home.asp Public Health Image Library] Image #5610]]
  −
[[Image:Kinetics of FeLV 2.jpg|thumb|right|150px|Kinetics of FeLV - Copyright Dr Brian Catchpole BVetMed PhD MRCVS]]
  −
*Oncogenic retrovirus
  −
*Causes neoplasia (lymphoma), myelosuppression (anaemia) and immunosuppression (of [[Lymphocytes#T cells|T cells]])
  −
*2 strains:
  −
**FeLV-A
  −
***Natural strain
  −
**FeLV-B
  −
***Formed through FeLV-A recombining with endogenous retroviral sequences in the feline genome
  −
***Increases the risks of lymphoma
  −
**FeLV-C
  −
***Formed from the spontaneous mutation of FeLV-A
  −
***Is more myelosuppressive
  −
*Virus replicates in the oropharyngeal lymphoid tissue causing a viraemia (virus circulating in the bloodstream) which then spreads to the systemic lymphoid tissue
  −
*Shed in saliva
  −
*Passed by oronasal route, e.g. mutual grooming
  −
*Kittens between 6 weeks and 6 months are most susceptible
  −
*60% of cats will become immune to the disease and recover
  −
*Cats that are persistently viraemic will progress to develop FeLV-associated diseases
  −
*Some cats will become viraemic again if treated with corticosteroids or stressed if the infection lies dormant in the [[Bone Marrow - Anatomy & Physiology|bone marrow]]
      
==Treatment==
 
==Treatment==
**Antibiotics for secondary infection
+
Where treatment is undertaken, anti-retroviral therapy is indicated with antibiotics to control secondary infections. Prevention is a key element in the control and treatment of FeLV overall.
**Anti-retroviral therapy
  −
*For vaccinations see [[Vaccines#Cat Vaccinations|here]]
  −
 
      +
{{Learning
 +
|Vetstream = [https://www.vetstream.com/felis/Content/Disease/dis60141 Feline leukemia virus disease]
 +
}}
      −
[[Category:Mammalian Type C retrovirus ]][[Category:Cat]][[Category:Secondary Immunodeficiency]]
+
[[Category:Mammalian Type C retrovirus ]][[Category:Cat Viruses]][[Category:Lymphoreticular and Haematopoietic Diseases - Cat]][[Category:Alimentary Diseases - Cat]][[Category:Secondary Immunodeficiency]]
[[Category:To_Do_-_Clinical/Viruses]]
+
[[Category:Lymphoreticular and Haemopoietic Diseases]]
[[Category:To Do - Blood]][[Category:To Do - Clinical]][[Category:Lymphoreticular and Haemopoietic Diseases]]
+
[[Category:Anaemia|6]]
 +
[[Category:Integumentary System - Viral Infections]]

Navigation menu